Dr. Johnny Suren Srabian

D.D.S. | Dentist



  
  370 Birchwood Cir, Murphy
  North Carolina, 28906-9047

  239-823-2801    Maps & Directions
Dr. Johnny Suren Srabian is a Murphy, North Carolina based Dentist who is specialized in Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 370 Birchwood Cir, Murphy. Patients can reach him at 239-823-2801.
Dr. Johnny Suren Srabian is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Johnny Suren Srabian speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Johnny Suren Srabian
Specialization: Dentist
Gender:Male
Credentials: D.D.S.
Accepts Medicare Assignment:May Accept
Practice Address:370 Birchwood Cir, Murphy,
North Carolina, 28906-9047
Phone:239-823-2801
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 4880958024
Enrollment ID: I20180516000244
NPI Number: 1255655858
NPI Enumeration Date: 25 Mar, 2010
NPI Last Update On: 25 Mar, 2010

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 370 Birchwood Cir,
Murphy, North Carolina
Zip: 28906-9047
Phone Number: 239-823-2801
Patients can reach Dr. Johnny Suren Srabian at 370 Birchwood Cir, Murphy, North Carolina or can call to book an appointment on 239-823-2801. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.

Comments/ Reviews: